Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Gemtuzumab ozogamicin |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Product containing infliximab (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
Product containing monoclonal antibody (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Monoclonal antibody |
Inferred relationship |
Some |
1 |
Product containing abciximab (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
Product containing daclizumab (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
Product containing basiliximab (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
Product containing etanercept (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
abciximab 2 mg/mL, fiole de 5 mL de solution pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
Product containing trastuzumab (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
Trastuzumab 150 mg powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
Mouse monoclonal antibody |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
Muromonab-CD3 1mg/mL injection solution 5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
Product containing murine-human monoclonal immunoglobulin G antibody |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
Infliximab 100mg powder for infusion solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
Etanercept 25mg powder and solvent for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
Abciximab 10mg/5 mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
Etanercept 25mg/vial powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
Trastuzumab 440 mg powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
Daclizumab 25mg/5 mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
Basiliximab 20mg/vial powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
Infliximab 100mg/vial injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
Product containing ibritumomab tiuxetan (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
Ibritumomab tiuxetan 3.2mg injection solution 2mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
Palivizumab (substance) |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Rituximab (substance) |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Product containing alemtuzumab (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
Alemtuzumab 30mg/3mL infusion concentrate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
anticorps monoclonal contre Escherichia coli |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
Canine lymphoma monoclonal antibody |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
Product containing adalimumab (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
Infliximab 100 mg powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
Omalizumab (substance) |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Efalizumab (substance) |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Tositumomab (substance) |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Daclizumab 25mg/5mL infusion concentrate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
Basiliximab 20mg injection (pdr for recon)+solvent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
Basiliximab 10mg injection (pdr for recon)+solvent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
Adalimumab 40mg injection solution 0.8mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
Alemtuzumab 30mg/3mL infusion concentrate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
Infliximab (substance) |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Adalimunab 40mg/mL injection solution 1mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
Product containing cetuximab (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
Cetuximab 2mg/mL injection solution 50mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
Product containing bevacizumab (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
Bevacizumab 25mg/mL injection solution 4mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
Bevacizumab 25mg/mL injection solution 16mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
Ibritumomab tiuxetan |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
Ibritumomab tiuxetan 1.6mg/mL radiopharmaceutical infusion kit |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
Product containing muromonab-CD3 (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
Natalizumab (substance) |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Etanercept 25mg/vial powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
Alemtuzumab 30mg/mL infusion concentrate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
agent d'anticorps monoclonal |
Is a |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
Iodine (124-I) labeled monoclonal antibody (substance) |
Is a |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
Panitumumab (substance) |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Product containing murine-human monoclonal immunoglobulin G antibody |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
Mouse monoclonal antibody |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
Product containing ustekinumab (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
Belimumab (substance) |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Besilesomab (substance) |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Brentuximab vedotin (substance) |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Alirocumab (substance) |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Idarucizumab (substance) |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Necitumumab (substance) |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Daratumumab (substance) |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Blinatumomab (substance) |
Is a |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
Olaratumab (substance) |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Bezlotoxumab (substance) |
Is a |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
Dinutuximab (substance) |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Ixekizumab (substance) |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Obiltoxaximab (substance) |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Raxibacumab (substance) |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Brodalumab (substance) |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Avelumab (substance) |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Ocrelizumab |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Dupilumab |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Muromonab-CD3 |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
anticorps monoclonal chimérique souris-humain d'isotype IgG |
Is a |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
Ibritumomab tiuxetan (substance) |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Adalimumab (substance) |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Bevacizumab (substance) |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Ranibizumab (substance) |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Eculizumab (substance) |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Zanolimumab (substance) |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Oregovomab (substance) |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Certolizumab pegol (substance) |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Naptumomab (substance) |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Golimumab |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Ustekinumab (substance) |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Tocilizumab (substance) |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Denosumab (substance) |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Canakinumab (substance) |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Nivolumab (substance) |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Pertuzumab |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Vedolizumab |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Ramucirumab |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Siltuximab |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Secukinumab |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Obinutuzumab (substance) |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|
Catumaxomab |
Is a |
False |
Monoclonal antibody |
Inferred relationship |
Some |
|
Elotuzumab (substance) |
Is a |
True |
Monoclonal antibody |
Inferred relationship |
Some |
|